Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 38

Sort by

Sort Order Select

Journal Articles

Thrombosis and novel hemophilia therapies: the fine line between clotting and bleeding

Maureane Hoffman

Blood Adv (2021) 5 (18): 3736.

https://doi.org/10.1182/bloodadvances.2021004802

Published: 2021

Includes: Supplemental data

Journal Articles

Concizumab: a novel anti-TFPI therapeutic for hemophilia

Amy D. Shapiro

Blood Adv (2021) 5 (1): 279.

https://doi.org/10.1182/bloodadvances.2019001140

Published: 2021

Includes: Supplemental data

Journal Articles

Gene therapy for hemophilia: anticipating the unexpected

Glenn F. Pierce

Blood Adv (2020) 4 (15): 3788.

https://doi.org/10.1182/bloodadvances.2020002142

Published: 2020

Includes: Supplemental data

Journal Articles

Recombinant vs plasma-derived von Willebrand factor to prevent postpartum hemorrhage in von Willebrand disease

Nicoletta Machin, Margaret V. Ragni

Blood Adv (2020) 4 (14): 3234–3238.

https://doi.org/10.1182/bloodadvances.2020002046

Published: 2020

Journal Articles

First report of emicizumab use in a female patient with severe hemophilia A

Géraldine Verstraete, Catherine Lambert, Cedric Hermans

Blood Adv (2020) 4 (13): 2950–2952.

https://doi.org/10.1182/bloodadvances.2020002364

Published: 2020

Journal Articles

Gut dysbiosis modulates the immune response to factor VIII in murine hemophilia A

Julie Tarrant, Matthew Cormier, Kate Nesbitt, Courtney Dwyer, Christine Hough, David Lillicrap

Blood Adv (2020) 4 (12): 2644–2655.

https://doi.org/10.1182/bloodadvances.2019001144

Published: 2020

Includes: Supplemental data

Journal Articles

Young adult outcomes of childhood prophylaxis for severe hemophilia A: results of the Joint Outcome Continuation Study

Beth Boulden Warren, Dianne Thornhill, Jill Stein, Michael Fadell, J. David Ingram, Sharon Funk, Kristi L. Norton, Heidi D. Lane, Carolyn M. Bennett, Amy Dunn, Michael Recht, Amy Shapiro, Marilyn J. Manco-Johnson

Blood Adv (2020) 4 (11): 2451–2459.

https://doi.org/10.1182/bloodadvances.2019001311

Published: 2020

Includes: Supplemental data

Journal Articles

Laboratory monitoring of hemophilia A treatments: new challenges

Peter J. Lenting

Blood Adv (2020) 4 (9): 2111–2118.

https://doi.org/10.1182/bloodadvances.2019000849

Published: 2020

Journal Articles

Maternal microchimerism protects hemophilia A patients from inhibitor development

Yeling Lu, Zhenping Chen, Jing Dai, Xi Wu, Hao Gu, Zekun Li, Jian Li, Qiulan Ding, Wenman Wu, Runhui Wu, Xuefeng Wang

Blood Adv (2020) 4 (9): 1867–1869.

https://doi.org/10.1182/bloodadvances.2020001832

Published: 2020

Journal Articles

MRI predicts 5-year joint bleeding and development of arthropathy on radiographs in hemophilia

Wouter Foppen, Irene C. van der Schaaf, Frederik J. A. Beek, Willem P. T. M. Mali, Kathelijn Fischer

Blood Adv (2020) 4 (1): 113–121.

https://doi.org/10.1182/bloodadvances.2019001238

Published: 2020

Journal Articles

The severe spontaneous bleeding phenotype in a novel hemophilia A rat model is rescued by platelet FVIII expression

Qizhen Shi, Jeremy G. Mattson, Scot A. Fahs, Aron M. Geurts, Hartmut Weiler, Robert R. Montgomery

Blood Adv (2020) 4 (1): 55–65.

https://doi.org/10.1182/bloodadvances.2019000944

Published: 2020

Journal Articles

Improving access to hemophilia care in sub-Saharan Africa by capacity building

Saliou Diop, Assad Haffar, Johnny Mahlangu, Irene Chami, Steve Kitchen, Glenn Pierce

Blood Adv (2019) 3 (Supplement 1): 1–4.

https://doi.org/10.1182/bloodadvances.2019GS121537

Published: 2019

Journal Articles

Building a network for hemophilia care in China: 15 years of achievement for the Hemophilia Treatment Center Collaborative Network of China

Renchi Yang, Man-Chiu Poon, Koon Hung Luke, Yongqiang Zhao, Jing Sun, Xuefeng Wang, Runhui Wu, Lixia Chen, Xinsheng Zhang, Jingsheng Wu

Blood Adv (2019) 3 (Supplement 1): 34–37.

https://doi.org/10.1182/bloodadvances.2019GS121524

Published: 2019

Journal Articles

Induction of activated T follicular helper cells is critical for anti-FVIII inhibitor development in hemophilia A mice

Weiqing Jing, Juan Chen, Yuanhua Cai, Yingyu Chen, Jocelyn A. Schroeder, Bryon D. Johnson, Weiguo Cui, Qizhen Shi

Blood Adv (2019) 3 (20): 3099–3110.

https://doi.org/10.1182/bloodadvances.2019000650

Published: 2019

Includes: Supplemental data

Journal Articles

High-level protein production in erythroid cells derived from in vivo transduced hematopoietic stem cells

Hongjie Wang, Zhinan Liu, Chang Li, Sucheol Gil, Thalia Papayannopoulou, Christopher B. Doering, André Lieber

Blood Adv (2019) 3 (19): 2883–2894.

https://doi.org/10.1182/bloodadvances.2019000706

Published: 2019

Includes: Supplemental data

Journal Articles

Nongenotoxic antibody-drug conjugate conditioning enables safe and effective platelet gene therapy of hemophilia A mice

Chunyan Gao, Jocelyn A. Schroeder, Feng Xue, Weiqing Jing, Yuanhua Cai, Amelia Scheck, Saravanan Subramaniam, Sridhar Rao, Hartmut Weiler, Agnieszka Czechowicz, Qizhen Shi

Blood Adv (2019) 3 (18): 2700–2711.

https://doi.org/10.1182/bloodadvances.2019000516

Published: 2019

Includes: Supplemental data

Journal Articles

Mitigation of T-cell dependent immunogenicity by reengineering factor VIIa analogue

Wojciech Jankowski, Joseph McGill, H. A. Daniel Lagassé, Stepan Surov, Gary Bembridge, Campbell Bunce, Edward Cloake, Mark H. Fogg, Katarzyna I. Jankowska, Abdul Khan, Joseph Marcotrigiano, Mikhail V. Ovanesov, Zuben E. Sauna

Blood Adv (2019) 3 (17): 2668–2678.

https://doi.org/10.1182/bloodadvances.2019000338

Published: 2019

Includes: Supplemental data

Journal Articles

Infused factor VIII–expressing platelets or megakaryocytes as a novel therapeutic strategy for hemophilia A

Randolph B. Lyde, Hyun Sook Ahn, Karen K. Vo, Danuta J. Jarocha, John Tkaczynski, Elsa Treffeisen, Spencer K. Sullivan, Rodney M. Camire, Denise E. Sabatino, Deborah L. French, Mortimer Poncz

Blood Adv (2019) 3 (9): 1368–1378.

https://doi.org/10.1182/bloodadvances.2017007914

Published: 2019

Includes: Supplemental data

Journal Articles

Gene-based FVIIa prophylaxis modulates the spontaneous bleeding phenotype of hemophilia A rats

Shannon M. Zintner, Juliana C. Small, Giulia Pavani, Lynn Dankner, Oscar A. Marcos-Contreras, Phyllis A. Gimotty, Mads Kjelgaard-Hansen, Bo Wiinberg, Paris Margaritis

Blood Adv (2019) 3 (3): 301–311.

https://doi.org/10.1182/bloodadvances.2018027219

Published: 2019

Includes: Supplemental data

Journal Articles

Reduced bone formation in males and increased bone resorption in females drive bone loss in hemophilia A mice

M. Neale Weitzmann, Susanne Roser-Page, Tatyana Vikulina, Daiana Weiss, Li Hao, W. Hunter Baldwin, Kanglun Yu, Natalia del Mazo Arbona, Meghan E. McGee-Lawrence, Shannon L. Meeks, Christine L. Kempton

Blood Adv (2019) 3 (3): 288–300.

https://doi.org/10.1182/bloodadvances.2018027557

Published: 2019

Includes: Supplemental data

NARROW

Thrombosis and novel hemophilia therapies: the fine line between clotting and bleeding

Concizumab: a novel anti-TFPI therapeutic for hemophilia

Gene therapy for hemophilia: anticipating the unexpected

Recombinant vs plasma-derived von Willebrand factor to prevent postpartum hemorrhage in von Willebrand disease

First report of emicizumab use in a female patient with severe hemophilia A

Gut dysbiosis modulates the immune response to factor VIII in murine hemophilia A

Young adult outcomes of childhood prophylaxis for severe hemophilia A: results of the Joint Outcome Continuation Study

Laboratory monitoring of hemophilia A treatments: new challenges

Maternal microchimerism protects hemophilia A patients from inhibitor development

MRI predicts 5-year joint bleeding and development of arthropathy on radiographs in hemophilia

The severe spontaneous bleeding phenotype in a novel hemophilia A rat model is rescued by platelet FVIII expression

Improving access to hemophilia care in sub-Saharan Africa by capacity building

Building a network for hemophilia care in China: 15 years of achievement for the Hemophilia Treatment Center Collaborative Network of China

Induction of activated T follicular helper cells is critical for anti-FVIII inhibitor development in hemophilia A mice

High-level protein production in erythroid cells derived from in vivo transduced hematopoietic stem cells

Nongenotoxic antibody-drug conjugate conditioning enables safe and effective platelet gene therapy of hemophilia A mice

Mitigation of T-cell dependent immunogenicity by reengineering factor VIIa analogue

Infused factor VIII–expressing platelets or megakaryocytes as a novel therapeutic strategy for hemophilia A

Gene-based FVIIa prophylaxis modulates the spontaneous bleeding phenotype of hemophilia A rats

Reduced bone formation in males and increased bone resorption in females drive bone loss in hemophilia A mice

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only